Cardio Diagnostics Holdings Inc. Common stock

CDIONASDAQ • USD
ThemeGenomics & Precision Med.›Precision Medicine Platforms
1.96 USD
↘ 0.15 (7.11%)AT CLOSE (11:59 AM EDT)
2.05
↗ 0.09 (4.39%)
POST MARKET (AS OF 07:40 PM EDT)
Post Market
AS OF 07:40 PM EDT
2.05
↗ 0.09 (4.39%)
🔴Market: CLOSED
Open?$2.06
High?$2.14
Low?$1.89
Prev. Close?$2.11
Volume?64.8K
Avg. Volume?75.8K
VWAP?$2.02
Rel. Volume?0.86x
Bid / Ask
Bid?$1.94 × 1.5K
Ask?$2.15 × 600
Spread?$0.21
Midpoint?$2.05
Valuation & Ratios
Market Cap?5.8M
Shares Out?3.0M
Float?2.7M
Float %?91.0%
P/E Ratio?N/A
P/B Ratio?0.65
EPS?-$2.25
Dividend?0.00%
Ex-Dividend?N/A

CDIO is currently priced at $1.96. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place CDIO at a fair price relative to peers.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.
Themes
Healthcare - Genomics & Precision Medicine›Precision Medicine PlatformsAI & Machine Learning›AI-Powered Analytics & Decision SystemsMedical Devices & HealthTech›Diagnostic Imaging & Equipment
Employees
17
Market Cap
5.8M
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Website
www.cdio.ai
Listed
2022-10-26
Address
311 W. SUPERIOR STREET
CHICAGO, IL 60645
Phone: 855-226-9991
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
1
Momentum?
50
Short Sent.?
100
Piotroski F-Score?2/9Weak
Altman Z-Score?-0.62Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.71%Low
Short Interest?19.0K
Days to Cover?1.0
Free Float2.7M
Avg Daily Volume85.1K
Settlement Date2026-05-15
Financial Health
Current Ratio?15.76Strong
Quick Ratio?15.76Strong
Cash Ratio?14.40Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.65CHEAP▾
P/S?
Peers
100
S&P
3
350.17HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.2CHEAP▾
EV/Sales?
S&P
97
-77.06CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-74.7%WEAK▾
ROA?
S&P
3
-69.6%WEAK▾
Cash Flow & Enterprise
FCF?$-6072234
Enterprise Value?$-1276462
Fundamentals ratios updated end of day
MarketsMoversWatchlist